摘要
目的:探讨重性精神疾病管理治疗项目在精神分裂症防治中的价值。方法:将56例精神分裂症患者分为符合重性精神疾病管理治疗项目规定的治疗组和对照组各28例。对照组实行常规治疗,即药物治疗、集体心理治疗及工娱疗法,接受普通门诊复查。治疗组在常规治疗基础上,根据项目要求每1个月进行随访观察及家属护理教育等。在入组时、出院后均采用简明精神病量表(BPRS)、大体量表(GAS)、社会功能缺陷量表(SDSS)进行评定。采用疾病家庭负担量表(FBS)评定家庭负担,每6个月评定一次。结果:治疗组BPRS评分明显高于对照组(t=2.03,P<0.05);复发率显著降低(χ2=3.90,P<0.05);经济负担和心理影响显著降低(P<0.05或<0.01)。结论:重性精神疾病管理治疗项目可以提高精神分裂症患者大体功能水平,减轻患者家庭的经济负担和心理影响,值得在更大范围内推广。
Objective:To investigate the value of severe mental disease management project in the the prevention and treatment of schizophrenia. Methods :56 patients with schizophrenia were randomly divided into the treatment group and the control group, the control group was treated by normal therapy, the treatment group was treated by the severe mental disease management project. 6 months after treatment, the effect was assessed by Brief Psychiatric Rating Scale (BPRS), GAS, SDSS and Family Burden Scale (FBS). Results:The score of BPRS in the treatment group was higher than that in the control group ( P 〈 O. 05 ). Conclusion : The manage project of severe psychosis can not only improve and control the condition effectively, but also enhance health status, labor capacity and quality of life in patients with severe psychosis.
出处
《中国民康医学》
2013年第22期20-22,共3页
Medical Journal of Chinese People’s Health
基金
十堰市科学技术研究与开发项目(082S)